rs1554695160
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_005458.8(GABBR2):c.1805G>C(p.Gly602Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,445,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G602G) has been classified as Likely benign.
Frequency
Consequence
NM_005458.8 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 59Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with poor language and loss of hand skillsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABBR2 | NM_005458.8 | c.1805G>C | p.Gly602Ala | missense_variant | Exon 13 of 19 | ENST00000259455.4 | NP_005449.5 | |
| GABBR2 | XM_017015331.3 | c.1511G>C | p.Gly504Ala | missense_variant | Exon 12 of 18 | XP_016870820.1 | ||
| GABBR2 | XM_005252316.6 | c.1031G>C | p.Gly344Ala | missense_variant | Exon 11 of 17 | XP_005252373.1 | ||
| GABBR2 | XM_017015332.3 | c.1031G>C | p.Gly344Ala | missense_variant | Exon 10 of 16 | XP_016870821.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1445396Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 719186 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Epileptic encephalopathy Uncertain:1
This sequence change replaces glycine with alanine at codon 602 of the GABBR2 protein (p.Gly602Ala). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and alanine. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with GABBR2-related disease. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at